JZJinwei Zhang

Jinwei Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinwei Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chenghai Li

    State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China; NMPA Key Laboratory for Quality Evaluation of Ultrasonic Surgical Equipment, Wuhan, 430075, China

    2 shared publications
  • Faqi Li

    Chongqing Medical University

    2 shared publications
  • C. Gong

    State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering Chongqing Medical University Chongqing China

    1 shared publication
  • C. Yang

    State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering Chongqing Medical University Chongqing China

    1 shared publication
  • Chao Yang

    State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University

    1 shared publication
  • Chunmei Gong

    State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Key Laboratory of Biomedical Engineering, Chongqing Medical University

    1 shared publication

Latest Publications

  • Open Access

    Prediction using T2‐weighted magnetic resonance imaging‐based radiomics of residual uterine myoma regrowth after high‐intensity focused ultrasound ablation

    by Y. Zhou, J. Zhang, J. Chen, C. Yang, C. Gong, C. Li, F. Li

    Objectives: To develop and evaluate magnetic resonance imaging (MRI)‐based radiomics models for predicting residual myoma regrowth within 1 year after high‐intensity focused ultrasound (HIFU) ablation of uterine myomas.Methods: A retrospective analysis of residual myoma regrowth within 1 year was performed on 428 myomas in 339 patients who were diagnosed with uterine myoma and treated with HIFU ablation in two hospital centers. In total, 851 radiomics features were extracted from T2‐weighted images (T2WI) obtained 1 day after HIFU ablation, and the least absolute shrinkage and selection operator in the training cohort (n = 243) was employed to select radiomics features. Support vector machines were adopted to develop radiomics, clinicoradiological and combined radiomics–clinical models to predict residual myoma regrowth, defined as an increase in residual myoma volume of > 10% between that at day 1 post HIFU and that at follow‐up MRI within 1 year. These models were validated in both internal (n = 81) and external (n = 104) test cohorts. The predictive performance and clinical application of these models were assessed using receiver‐operating‐characteristics‐curve analysis, the area under the curve (AUC) and decision‐curve analysis.Results: The AUCs of the T2WI‐based radiomics prediction model in the internal and external test cohorts were 0.834 (95% CI, 0.747–0.920) and 0.801 (95% CI, 0.712–0.889), respectively, and those of the clinicoradiological model were 0.888 (95% CI, 0.816–0.960) and 0.912 (95% CI, 0.851–0.973), respectively. The combined model had better predictive performance than either the radiomics or the clinicoradiological model, with AUC values of 0.922 (95% CI, 0.857–0.987) and 0.930 (95% CI, 0.880–0.980) in the internal and external test cohorts, respectively. Decision‐curve analysis also indicated that application of the combined model has clinical value, this model achieving more net benefits than the other two models.Conclusion: T2WI‐based radiomics features can predict effectively the occurrence of residual myoma regrowth within 1 year after HIFU ablation of uterine myomas, which serves as an accurate and convenient reference for clinical decision‐making. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    Magnetic resonance imaging parameter-based machine learning for prognosis prediction of high-intensity focused ultrasound ablation of uterine fibroids

    by Jinwei Zhang, Chao Yang, Chunmei Gong, Ye Zhou, Chenghai Li, Faqi Li

    Objectives: To develop and apply magnetic resonance imaging (MRI) parameter-based machine learning (ML) models to predict non-perfused volume (NPV) reduction and residual regrowth of uterine fibroids after high-intensity focused ultrasound (HIFU) ablation. Methods: MRI data of 573 uterine fibroids in 410 women who underwent HIFU ablation from the Chongqing Haifu Hospital (training set, N = 405) and the First Affiliated Hospital of Chongqing Medical University (testing set, N = 168) were retrospectively analyzed. Fourteen MRI parameters were screened for important predictors using the Boruta algorithm. Multiple ML models were constructed to predict NPV reduction and residual fibroid regrowth in a median of 203.0 (interquartile range: 122.5–367.5) days. Furthermore, optimal models were used to plot prognostic prediction curves. Results: Fourteen features, including postoperative NPV, indicated predictive ability for NPV reduction. Based on the 10-fold cross-validation, the best average performance of multilayer perceptron achieved with R2 was 0.907. In the testing set, the best model was linear regression (R2 =0.851). Ten features, including the maximum thickness of residual fibroids, revealed predictive power for residual fibroid regrowth. Random forest model achieved the best performance with an average area under the curve (AUC) of 0.904 (95% confidence interval (CI), 0.869–0.939), which was maintained in the testing set with an AUC of 0.891 (95% CI, 0.850–0.929). Conclusions: ML models based on MRI parameters can be used for prognostic prediction of uterine fibroids after HIFU ablation. They can potentially serve as a new method for learning more about ablated fibroids.